Understanding of COVID‐19 based on current evidence
By P. Sun, Xiaosheng Lu, Chao Xu, Wenjuan Sun, Bo Pan. Journal of Medical Virology, 2020
979 citations recorded by the source corpus.
Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019‐nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019‐nCoV as coronavirus disease (COVID‐19). The COVID‐19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID‐19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID‐19 epidemic.
Subfields: Infectious Diseases, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/a42902bc3f4d92b72f46775420be6569d19e3f73
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Andrea Ascani
- Sandro Montresor
- Xiaofeng Zeng
- Shuyang Zhang
- Xuan Zhang
- Wen Zhang
- Yan Qin
- Zheng-yin Liu
Citations in the corpus
- Behavioral immune system linked to responses to the threat of COVID-19 (2020, neutral): “Meanwhile, medical research demonstrates that men are more likely to experience worse consequences of getting sick with COVID-19 (Sun et al., 2020).”
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease (2020, neutral): “SARS-CoV-2 samples were detected in this market, but the infected animal species has not been definitively established at the time of writing [4].”
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China (2020, background): “[3,23,24] However, there is no evidence from randomized clinical trials to support glucocorticoids treatment for COVID-19.”
- The geography of COVID‐19 and the structure of local economies: The case of Italy (2020, background): “Furthermore, we include in our analysis the provincial proportion of male population in 2018, as males seem to be more susceptible of infections according to a number of recent scientific findings (Sun et al., 2020; Wang et al., 2020).”